Maya Jeje Schuang Lü, Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

Urup, T., Gillberg, L., Kaastrup, K., Lü, M., Michaelsen, S., Larsen, V., Christensen, I., Broholm, H., Lassen, U., Grønbæk, K., Poulsen, H. (2020) ”Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma”, Mol Oncol. doi: 10.1002/1878-0261.12660